Tirzepatide is given as a once-weekly injection under the skin, usually in the abdomen, thigh, or upper arm
Tang Y, Arbaugh B, Park H, Scher HB, Bai L, Mao L, et al
Retatrutide is not currently approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK
doi: 10.1111/nmo.12829 23 DubocH.RainteauD.RajcaS.HumbertL.FarabosD.MaubertM.et al
In the SURPASS trials, malignant neoplasms were reported at rates similar to those observed with comparator agents including placebo, insulin, and other GLP-1 receptor agonists
Here are some common situations where treatments are often recommended include: Persistent facial redness: If facial redness caused by rosacea persists or worsens over time, despite avoiding triggers and implementing self-care measures, treatment may be necessary